Impax Asset Management Group plc trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical research company’s stock after selling 413 shares during […]
Silvant Capital Management LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 shares during the period. Silvant […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CFO Jeffrey Thomas Elliott sold 2,710 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $154,171.90. Following the transaction, the chief financial officer now owns 8,054 shares of the […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CFO Jeffrey Thomas Elliott sold 1,888 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $61.43, for a total value of $115,979.84. Following the completion of the transaction, the chief financial officer now […]
Westpac Banking Corp lessened its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 45.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,000 shares of the medical research company’s stock after selling 6,631 shares during the quarter. Westpac Banking […]